β-Glucuronyl carbamate based pro-moieties designed for prodrugs in ADEPT
- 6 March 1995
- journal article
- Published by Elsevier in Tetrahedron Letters
- Vol. 36 (10) , 1701-1704
- https://doi.org/10.1016/0040-4039(95)00049-i
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Design of Antitumor Prodrugs: Substrates for Antibody Targeted EnzymesChemical Reviews, 1994
- Tumor targeting: Activation of prodrugs by enzyme-monoclonal antibody conjugatesTrends in Biotechnology, 1994
- Relationships between structure and kinetics of cyclization of 2-aminoaryl amides: potential prodrugs of cyclization-activated aromatic mustardsJournal of Medicinal Chemistry, 1994
- Antibody-directed enzyme prodrug therapy (Adept)Journal of Controlled Release, 1994
- Generation of cytotoxic agents by targeted enzymesBioconjugate Chemistry, 1993
- A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancerBritish Journal of Cancer, 1992
- The lactonization of 2'-hydroxyhydrocinnamic acid amides: a potential prodrug for aminesThe Journal of Organic Chemistry, 1990
- Prodrugs based on masked lactones. Cyclization of .gamma.-hydroxy amidesThe Journal of Organic Chemistry, 1988
- Prodrugs as drug delivery systems. Part 42. 2-Hydroxymethylbenzamides and 2-acyloxymethylbenzamides as potential prodrug forms for aminesInternational Journal of Pharmaceutics, 1986
- Diphenylphosphoryl azide. New convenient reagent for a modified Curtius reaction and for peptide synthesisJournal of the American Chemical Society, 1972